Skip to main content

Table 4 Clinical pregnancy cycle characteristics

From: Expression of antiapoptosis gene survivin in luteinized ovarian granulosa cells of women undergoing IVF or ICSI and embryo transfer: clinical correlations

Characteristics Clinical pregnancy  
  No Yes p value*
  Median [IQR] Median [IQR]  
Age (years) 36.00 (33.00, 37.00) 38.00 (36.00, 44.00) 0.069
FSH (IU/L) 6.3 (5.50, 7.90) 5.5 (4.10, 8.50) 0.634
PRL (ng/mL) 12.10 (7.20, 16.1) 19.20 (11.70, 22.60) 0.054
Total gonadotropin dosage 3,075.00 (2,275.00, 3,675.00) 2,625.00 (2,325.00, 3,175.00) 0.398
Estradiol, 5th day of rFSH administration (pg/mL) 400.00 (252.00, 691.00) 450.00 (309.00, 509.00) 0.572
Estradiol, peak (pg/mL) 2,022.00 (1,561.00, 2,569.00) 2,188.50 (1,254.00, 2,805.00) 0.686
Number of oocytes retrieved 8.00 (6.00, 10.00) 9.00 (6.00, 10.00) 0.765
Mature oocyte ratio (%) 71.00 (60.00, 78.00) 68.50 (67.00, 83.00) 1.000
Survivin/ABL 0.50 (0.20, 3.00) 0.3 (0.20, 1.20) 0.246
  1. *Statistical Test.
  2. Clinical pregnancy in correlation with patients’ cycle characteristics and survivin/ABL genes expression.